{"id":"https://openalex.org/W200998688","doi":null,"title":"\u0411\u043b\u043e\u043a\u0430\u0442\u043e\u0440 \u0410\u04221\u0440\u0435\u0446\u0435\u043f\u0442\u043e\u0440\u043e\u0432 \u0430\u043d\u0433\u0438\u043e\u0442\u0435\u043d\u0437\u0438\u043d\u0430 II \u0432\u0430\u043b\u0441\u0430\u0440\u0442\u0430\u043d (\u0412\u0430\u043b\u0441\u0430\u0444\u043e\u0440\u0441) \u0432 \u0441\u043e\u0441\u0442\u0430\u0432\u0435 \u043a\u043e\u043c\u0431\u0438\u043d\u0438\u0440\u043e\u0432\u0430\u043d\u043d\u043e\u0439 \u0442\u0435\u0440\u0430\u043f\u0438\u0438 \u0443 \u043f\u0430\u0446\u0438\u0435\u043d\u0442\u043e\u0432 \u0441 \u0430\u0440\u0442\u0435\u0440\u0438\u0430\u043b\u044c\u043d\u043e\u0439 \u0433\u0438\u043f\u0435\u0440\u0442\u043e\u043d\u0438\u0435\u0439 \u0438 \u043e\u0436\u0438\u0440\u0435\u043d\u0438\u0435\u043c","display_name":"\u0411\u043b\u043e\u043a\u0430\u0442\u043e\u0440 \u0410\u04221\u0440\u0435\u0446\u0435\u043f\u0442\u043e\u0440\u043e\u0432 \u0430\u043d\u0433\u0438\u043e\u0442\u0435\u043d\u0437\u0438\u043d\u0430 II \u0432\u0430\u043b\u0441\u0430\u0440\u0442\u0430\u043d (\u0412\u0430\u043b\u0441\u0430\u0444\u043e\u0440\u0441) \u0432 \u0441\u043e\u0441\u0442\u0430\u0432\u0435 \u043a\u043e\u043c\u0431\u0438\u043d\u0438\u0440\u043e\u0432\u0430\u043d\u043d\u043e\u0439 \u0442\u0435\u0440\u0430\u043f\u0438\u0438 \u0443 \u043f\u0430\u0446\u0438\u0435\u043d\u0442\u043e\u0432 \u0441 \u0430\u0440\u0442\u0435\u0440\u0438\u0430\u043b\u044c\u043d\u043e\u0439 \u0433\u0438\u043f\u0435\u0440\u0442\u043e\u043d\u0438\u0435\u0439 \u0438 \u043e\u0436\u0438\u0440\u0435\u043d\u0438\u0435\u043c","publication_year":2011,"publication_date":"2011-01-01","ids":{"openalex":"https://openalex.org/W200998688","mag":"200998688"},"language":"ru","primary_location":{"id":"mag:200998688","doi":null,"is_oa":false,"landing_page_url":"https://cyberleninka.ru/article/n/blokator-at1retseptorov-angiotenzina-ii-valsartan-valsafors-v-sostave-kombinirovannoy-terapii-u-patsientov-s-arterialnoy-gipertoniey-i.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S4306539477","display_name":"\u041b\u0435\u0447\u0435\u0431\u043d\u043e\u0435 \u0434\u0435\u043b\u043e","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"\u041b\u0435\u0447\u0435\u0431\u043d\u043e\u0435 \u0434\u0435\u043b\u043e","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"\u041c. \u041b. \u041c\u0430\u043a\u0441\u0438\u043c\u043e\u0432","orcid":"https://orcid.org/0000-0003-3260-5672","observed_orcids":["https://orcid.org/0000-0003-3260-5672"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"\u041c. \u041b. \u041c\u0430\u043a\u0441\u0438\u043c\u043e\u0432","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3260-5672","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113868313","display_name":"\u0414\u0440\u0430\u043b\u043e\u0432\u0430 \u041e\u043b\u044c\u0433\u0430 \u0412\u0438\u043a\u0442\u043e\u0440\u043e\u0432\u043d\u0430","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"\u041e. \u0412. \u0414\u0440\u0430\u043b\u043e\u0432\u0430","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5024446773","display_name":"\u0415. \u0410. \u0414\u0435\u0440\u0431\u0435\u043d\u0446\u0435\u0432\u0430","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"\u0415. \u0410. \u0414\u0435\u0440\u0431\u0435\u043d\u0446\u0435\u0432\u0430","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":"4","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.6547999978065491,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.6547999978065491,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.3328000009059906,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11839","display_name":"Hormonal Regulation and Hypertension","score":0.0017999999690800905,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/valsartan","display_name":"valsartan","score":0.9990000128746033},{"id":"https://openalex.org/keywords/enalapril","display_name":"enalapril","score":0.8209999799728394},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.9179999828338623},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.7419999837875366},{"id":"https://openalex.org/keywords/angiotensin-receptor-blockers","display_name":"angiotensin receptor blockers","score":0.7850000262260437},{"id":"https://openalex.org/keywords/ace-inhibitors","display_name":"ACE inhibitors","score":0.7519999742507935},{"id":"https://openalex.org/keywords/renal-protection","display_name":"renal protection","score":0.7850000262260437},{"id":"https://openalex.org/keywords/dose-dependent-effects","display_name":"dose-dependent effects","score":0.609000027179718},{"id":"https://openalex.org/keywords/drug-safety-and-tolerability","display_name":"drug safety and tolerability","score":0.8840000033378601},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.9240000247955322},{"id":"https://openalex.org/keywords/sexual-function","display_name":"sexual function","score":0.9890000224113464}],"concepts":[{"id":"https://openalex.org/C2777387769","wikidata":"https://www.wikidata.org/wiki/Q155472","display_name":"Valsartan","level":3,"score":0.9056073427200317},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8455675840377808},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.7977993488311768},{"id":"https://openalex.org/C2775940317","wikidata":"https://www.wikidata.org/wiki/Q422185","display_name":"Enalapril","level":4,"score":0.7027139663696289},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.564446210861206},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.40707072615623474},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3398400545120239},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.26945924758911133},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.26484566926956177},{"id":"https://openalex.org/C27016395","wikidata":"https://www.wikidata.org/wiki/Q128861","display_name":"Angiotensin-converting enzyme","level":3,"score":0.13673317432403564}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:200998688","doi":null,"is_oa":false,"landing_page_url":"https://cyberleninka.ru/article/n/blokator-at1retseptorov-angiotenzina-ii-valsartan-valsafors-v-sostave-kombinirovannoy-terapii-u-patsientov-s-arterialnoy-gipertoniey-i.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S4306539477","display_name":"\u041b\u0435\u0447\u0435\u0431\u043d\u043e\u0435 \u0434\u0435\u043b\u043e","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"\u041b\u0435\u0447\u0435\u0431\u043d\u043e\u0435 \u0434\u0435\u043b\u043e","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W52690410","https://openalex.org/W1604449367","https://openalex.org/W3031241955","https://openalex.org/W2042587154","https://openalex.org/W48661685","https://openalex.org/W83958538","https://openalex.org/W2152284781","https://openalex.org/W7070269817","https://openalex.org/W2415889420","https://openalex.org/W4407942744"],"abstract_inverted_index":{"The":[0,60],"article":[1],"deals":[2],"with":[3,20],"the":[4,69],"study":[5],"that":[6],"showed":[7],"hypotensive":[8],"and":[9,13,25,35,41,52,68,75],"nephroprotective":[10,42],"efficacy,":[11],"safety":[12,58],"tolerability":[14],"of":[15,38,44,73],"combination":[16,63],"therapy":[17,32,64,70],"in":[18,50],"patients":[19,61],"stage":[21,26],"I-II":[22,27],"arterial":[23],"hypertension":[24],"abdominal":[28],"visceral":[29],"obesity.":[30],"Combination":[31],"included":[33],"enalapril":[34],"different":[36],"doses":[37,55],"valsartan.":[39],"Hypotensive":[40],"effects":[43],"valsartan":[45],"were":[46],"dose":[47],"dependent.":[48],"Valsartan":[49],"initial":[51],"moderate":[53],"therapeutic":[54],"had":[56],"high":[57],"profile.":[59],"assessed":[62],"as":[65],"well":[66],"tolerated":[67],"improved":[71],"quality":[72],"life":[74],"sexual":[76],"function.":[77]},"counts_by_year":[],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2016-06-24T00:00:00"}